Home / Inspections / 1055102

FDA Inspection 1055102 — Abbvie Biotechnology Ltd.

Abbvie Biotechnology Ltd. — FEI 3004620772

The FDA completed an inspection of Abbvie Biotechnology Ltd. on June 1, 2018 in Barceloneta, PR. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
June 1, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Barceloneta, PR (United States)

Facility

Other inspections at this facility

  • 1222107 (VAI Mon Oct 30 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1084057 (VAI Mon Mar 25 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1012249 (VAI Fri Apr 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 969277 (VAI Thu Mar 24 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 887947 (VAI Wed Jul 16 2014 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources